PanCAN answers questions that came in during our World Pancreatic Cancer Day event about pancreatic cancer early detection.

In a Phase III clinical trial, a therapy known as Tumor Treating Fields (TTFields) increased survival for patients whose ...

The U.S. Food and Drug Administration has granted accelerated approval for a new drug targeting a tumor alteration called ...

To speed research advancements and the development of better treatments and early detection tools, the Pancreatic Cancer Action Network (PanCAN) offers grants for basic, translational and clinical ...

It can be difficult to keep up with all of the new discoveries and information available about pancreatic cancer. Our webinars help you stay on top of the most relevant information about pancreatic ...

For decades, one of the biggest challenges facing the cancer research community has been finding a way to therapeutically target RAS, the most common oncogene in human cancer. An oncogene is a gene ...

Matthew Rose lost his mother, Estelle, to pancreatic cancer in 2012. He lost his sister to ovarian cancer years before that. Both were BRCA2 positive. Now the media chair for the Los Angeles Affiliate ...

The Rogers lost their matriarch, Renee, to pancreatic cancer 11 years ago. And for 11 years, her husband Denny, along with their children and others, have organized Renee’s Run events, held in Renee’s ...

Editor’s note: November is Pancreatic Cancer Awareness Month, an opportunity to shine a light on one of the deadliest cancers. This year, the Pancreatic Cancer Action Network (PanCAN) is raising ...

The Pancreatic Cancer Action Network (PanCAN) Executive Team is a group of dedicated professionals, some of whom have been personally touched by the disease, who bring significant experience and ...